Scenarios that move RNTX

Rein Therapeutics, Inc. - Common Stock

Scenarios that move RNTX: 1 analysis, 1 positive, 0 negative.

  1. · Syndax stock falls 16% as Phase II fibrosis study misses primary goal — ▲ · impact +40 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing